Proteasome inhibitors and IM iDs can overcome some high‐risk cytogenetics in multiple myeloma but not gain 1q21
Year: 2015
Type: article
Study design: Observational Study
Source: European Journal Of Haematology
DOI: 10.1111/ejh.12546
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2146659622
